Bennet's 'Breakthrough' Provision to get Lifesaving Drugs to Patients Yields First Designations
FDA Grants 2 Designations for Cystic Fibrosis Treatments
Jan 07, 2013
Colorado U.S. Senator Michael Bennet released the following statement after Vertex Pharmaceuticals announced two of its cystic fibrosis treatments were granted the first Breakthrough Therapy Designations from the U.S. Food and Drug Administration (FDA). The new breakthrough designations are the result of a provision Bennet passed i...